-
MRCY’s traditional EPS is materially distorted by the accounting for R&D
-
After making the appropriate UAFRS adjustments, EPS’ growth is expected to be robust, at 27% over the next year, and EPS’ is already well above levels as-reported metrics would suggest
-
At current valuations, the firm is not trading at a 2x-5x PEG, but instead a 1.1x PEG ratio, implying the firm is likely fairly valued, not well overpriced
Submitted May 07, 2017 at 10:20PM by Valens_Research http://ift.tt/2pb6jGs
No comments:
Post a Comment